Phase II Trial to Compare the Safety of Two Chemotherapy Plus Trastuzumab Regimens as Adjuvant Therapy for HER2-positive Breast Cancer (Study P05048)
Clinical trial NCT00550771 · COMPLETED
Trial details
- NCT number
- NCT00550771
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-16
- Primary completion
- 2010-08-23
- Enrollment
- 181
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.